You are here

Situation Report

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday.

...

 

 

 

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

EU’s Covid recovery fund under pressure to allocate unused funds

BRUSSELS — Governments have received less than a third of the EU's original €723 billion pot to help boost post-Covid economic recovery and are now heaping pressure on the European Commission to speed up payments.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID infections down in 29 states, up in only 2--CDC

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

US flu, COVID, RSV activity continues to recede --CDC

Respiratory virus activity in the United States is still elevated but continues to decline, with only 6 jurisdiction reporting high levels, down from 10 the previous week, the Centers for Disease Control and Prevention (CDC) said today in its data updates.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Situation Report
howdy folks